-
Personalized Medicine: A New Era in Healthcare
David Orchard-Webb
January 02, 2024
Personalized medicine, also known as precision or individualized medicine, is a rapidly evolving field where medical decisions are tailored to individual patients based on their genetic and genomic data.
-
GSK and Oxford University announce Oxford-GSK Institute of Molecular and Computational Medicine
expresspharma
December 03, 2021
The institute aims to improve the success and speed of research and development of new medicines, building on insights from human genetics and using advanced technologies such as functional genomics and machine learning.
-
Private genomics industry may be called upon to speed up strategic genome surveillance initiatives
expresspharma
April 06, 2021
How has the COVID-19 pandemic reinforced the value and significance of genomic surveillance? How can it play a critical role in making the world more informed and adept at preventing and curtailing future epidemics and pandemics?
-
New next-generation research platform launched by Genomics England
europeanpharmaceuticalreview
July 07, 2020
The genomic research platform will initially be used to help fast-track COVID-19 drug research and development, before being leveraged against other diseases, such as cancer.
-
GSK Partners with University of California for Genomic Research
contractpharma
June 19, 2019
New ‘Laboratory for Genomics Research’ unites CRISPR pioneers with industry expertise to help unravel mysteries of the human genome.
-
BluePrint® Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes
b3cnewswire
June 03, 2019
BluePrint® Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes.
-
Contextual Genomics launches new liquid biopsy test and updated solid tumor panel
fiercebiotech
January 04, 2019
Vancouver-based Contextual Genomics has launched two molecular hotspot assays for detecting genomic mutations in blood and solid tumors.....
-
Genomic profiling offers hope for rare cancer treatments
pharmaceutical-technology
November 14, 2018
A clinical trial led by Walter and Eliza Hall Institute of Medical Research in Australia has demonstrated that genomic profiling could help match rare cancer patients with appropriate treatments.
-
Genomic study directly links depression to obesity
pharmaceutical-technology
November 14, 2018
A genomic study conducted by the University of Exeter, UK, and the University of South Australia has found that higher body mass index (BMI) has a strong psychological association with depression, including in the absence of other health problems.